Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE).

PubWeight™: 4.53‹?› | Rank: Top 1%

🔗 View Article (PMID 18216052)

Published in Eur Respir J on January 23, 2008

Authors

J Vestbo1, W Anderson, H O Coxson, C Crim, F Dawber, L Edwards, G Hagan, K Knobil, D A Lomas, W MacNee, E K Silverman, R Tal-Singer, ECLIPSE investigators

Author Affiliations

1: Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark. joergen.vestbo@hvh.regionh.dk

Associated clinical trials:

Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints (ECLIPSE) | NCT00292552

Chronic Obstructive Pulmonary Disease Biomarker Study | NCT02050022

Prednisone Administration in Quiescent COPD Patients to Determine the Effect on Gene Expression | NCT02534402

Articles citing this

(truncated to the top 100)

Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54

Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res (2010) 5.17

Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet (2010) 3.91

Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet (2010) 3.44

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One (2012) 2.52

A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07

Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax (2013) 1.99

A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet (2011) 1.98

Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.72

Association Between Interstitial Lung Abnormalities and All-Cause Mortality. JAMA (2016) 1.61

Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD. Respir Res (2011) 1.52

Susceptibility to chronic mucus hypersecretion, a genome wide association study. PLoS One (2014) 1.52

Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 1.51

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res (2011) 1.43

Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD. Chronic Obstr Pulm Dis (2015) 1.43

Study on risk factors and phenotypes of acute exacerbations of chronic obstructive pulmonary disease in Guangzhou, China-design and baseline characteristics. J Thorac Dis (2015) 1.39

Altered regulation and expression of genes by BET family of proteins in COPD patients. PLoS One (2017) 1.36

Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. Am J Respir Crit Care Med (2010) 1.36

The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. PLoS One (2009) 1.28

Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respir Res (2010) 1.26

CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society. Radiology (2015) 1.24

Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.23

Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One (2014) 1.23

Lung function indices for predicting mortality in COPD. Eur Respir J (2013) 1.23

Genome-wide association study of smoking behaviours in patients with COPD. Thorax (2011) 1.18

The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am J Respir Cell Mol Biol (2011) 1.17

Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Respir Res (2011) 1.15

Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respir Res (2011) 1.13

Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS One (2011) 1.11

Assessment of small-airways disease using alveolar nitric oxide and impulse oscillometry in asthma and COPD. Lung (2010) 1.09

Factors associated with change in exacerbation frequency in COPD. Respir Res (2013) 1.08

Elevated airway purines in COPD. Chest (2011) 1.07

Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2010) 1.04

A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes. Am J Respir Crit Care Med (2015) 1.02

Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum. PLoS One (2012) 1.02

COPD and disease-specific health status in a working population. Respir Res (2013) 1.00

Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD. Respir Res (2013) 1.00

Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med (2015) 0.97

Biomarkers in exhaled breath condensate: a review of collection, processing and analysis. J Breath Res (2008) 0.95

An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 0.95

Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score. Am J Respir Crit Care Med (2015) 0.94

Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice. Nat Med (2016) 0.93

Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report. COPD (2011) 0.93

Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care. Mayo Clin Proc (2010) 0.93

Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. BMC Pulm Med (2014) 0.93

Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Hum Genet (2013) 0.92

Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study. BMJ Open (2013) 0.92

Association between vitamin D status and COPD phenotypes. Lung (2014) 0.92

Novel outcomes and end points: biomarkers in chronic obstructive pulmonary disease clinical trials. Proc Am Thorac Soc (2011) 0.92

Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease. Thorax (2011) 0.91

Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2010) 0.90

Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD. Int J Chron Obstruct Pulmon Dis (2013) 0.90

Genes and chronic obstructive pulmonary disease. Med Clin North Am (2012) 0.88

Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD. BMC Pulm Med (2014) 0.87

Altered gene expression in blood and sputum in COPD frequent exacerbators in the ECLIPSE cohort. PLoS One (2014) 0.86

Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations. Clin Med Insights Circ Respir Pulm Med (2011) 0.86

New clinical insights into chronic obstructive pulmonary disease and their implications for pharmacoeconomic analyses. Pharmacoeconomics (2012) 0.86

Pulmonary emphysema in cystic fibrosis detected by densitometry on chest multidetector computed tomography. PLoS One (2013) 0.85

Do females behave differently in COPD exacerbation? Int J Chron Obstruct Pulmon Dis (2015) 0.85

Variation in quantitative CT air trapping in heavy smokers on repeat CT examinations. Eur Radiol (2012) 0.85

Analysis of the plasma proteome in COPD: Novel low abundance proteins reflect the severity of lung remodeling. COPD (2013) 0.84

Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitis. Respir Res (2014) 0.84

The Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methods. BMC Pulm Med (2015) 0.83

Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe. Hum Mutat (2012) 0.83

Assessment of potential drug interactions by characterization of human drug metabolism pathways using non-invasive bile sampling. Br J Clin Pharmacol (2013) 0.83

DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease. Respir Res (2014) 0.82

Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study. Ann Am Thorac Soc (2014) 0.82

Genetic association between human chitinases and lung function in COPD. Hum Genet (2011) 0.82

Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values. Exp Ther Med (2016) 0.81

Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management. J Transl Med (2014) 0.81

Survival in COPD: impact of lung dysfunction and comorbidities. Medicine (Baltimore) (2014) 0.81

Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study. Respir Res (2012) 0.81

Evaluation of the COPD Assessment Test and GOLD patient types: a cross-sectional analysis. Int J Chron Obstruct Pulmon Dis (2015) 0.81

Analyzing networks of phenotypes in complex diseases: methodology and applications in COPD. BMC Syst Biol (2014) 0.80

Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease. Respir Res (2014) 0.80

A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in Chronic Obstructive Pulmonary Disease. BMC Syst Biol (2014) 0.80

Application of nitric oxide measurements in clinical conditions beyond asthma. Eur Clin Respir J (2015) 0.80

Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.79

Hyperpolarized 3He and 129Xe magnetic resonance imaging apparent diffusion coefficients: physiological relevance in older never- and ex-smokers. Physiol Rep (2014) 0.79

On the follow-up of genome-wide association studies: an overall test for the most promising SNPs. Genet Epidemiol (2011) 0.79

The Effect of Statins on Blood Gene Expression in COPD. PLoS One (2015) 0.79

Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD. Eur Respir J (2014) 0.79

Markers of early disease and prognosis in COPD. Int J Chron Obstruct Pulmon Dis (2009) 0.78

Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2014) 0.78

Chest CT measures of muscle and adipose tissue in COPD: gender-based differences in content and in relationships with blood biomarkers. Acad Radiol (2014) 0.78

COPD subtypes identified by network-based clustering of blood gene expression. Genomics (2016) 0.77

Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium. Patient Prefer Adherence (2015) 0.77

A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry. BMC Genet (2015) 0.77

Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. Nat Genet (2017) 0.77

Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease. BMC Pulm Med (2013) 0.77

Hyperpolarized 83Kr magnetic resonance imaging of alveolar degradation in a rat model of emphysema. J R Soc Interface (2015) 0.77

Airway wall area derived from 3-dimensional computed tomography analysis differs among lung lobes in male smokers. PLoS One (2014) 0.77

IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2015) 0.77

Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes (2012) 0.76

Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.76

High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study. Respir Res (2016) 0.76

Identifying a Deletion Affecting Total Lung Capacity Among Subjects in the COPDGene Study Cohort. Genet Epidemiol (2015) 0.76

Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients. Int J Chron Obstruct Pulmon Dis (2016) 0.76

Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study. NPJ Prim Care Respir Med (2017) 0.75

Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study. BMJ Open (2014) 0.75

Articles by these authors

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J (2004) 16.84

Particulate air pollution and acute health effects. Lancet (1995) 9.26

Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38

Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered (2003) 5.06

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem (2001) 4.81

Conformational disease. Lancet (1997) 4.53

Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med (2001) 4.25

Lac DNA, RNA polymerase and cyclic AMP receptor protein, cyclic AMP, lac repressor and inducer are the essential elements for controlled lac transcription. Nat New Biol (1971) 3.79

Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax (2009) 3.54

Ambient particle inhalation and the cardiovascular system: potential mechanisms. Environ Health Perspect (2001) 3.49

Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol (2001) 3.38

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr (1997) 3.38

The results of radical nephrectomy for renal cell carcinoma. J Urol (1969) 3.37

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med (2000) 3.08

Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med (1996) 3.04

CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J Immunol (1990) 2.94

Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89

Heterogeneity of therapeutic responses in asthma. Br Med Bull (2000) 2.86

Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol (2000) 2.70

Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J (2000) 2.63

Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. Thorax (2000) 2.62

Free radical activity and pro-inflammatory effects of particulate air pollution (PM10) in vivo and in vitro. Thorax (1996) 2.58

Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience (2005) 2.54

Randomised controlled study of orchidectomy vs long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma. Lancet (1985) 2.51

Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol (2000) 2.51

Further studies on the lactic acid, sugar and inorganic phosphorus of the blood of ruminants, (a) following adrenalectomy and (b) after intravenous injection of insulin. Biochem J (1934) 2.28

Telomere shortening in smokers with and without COPD. Eur Respir J (2006) 2.27

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax (2008) 2.25

Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem (2000) 2.24

Ultrafine particles. Occup Environ Med (2001) 2.23

Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ (1998) 2.22

The contribution of altered synapses in the senile plaque: an electron microscopic study in Alzheimer's dementia. J Neuropathol Exp Neurol (1967) 2.18

Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis (1997) 2.15

Adverse health effects of PM10 particles: involvement of iron in generation of hydroxyl radical. Occup Environ Med (1996) 2.12

Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest (1991) 2.11

Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med (2001) 2.11

CT measurements of lung density in life can quantitate distal airspace enlargement--an essential defining feature of human emphysema. Am Rev Respir Dis (1988) 2.06

First family planning visit in school-based clinics. J Sch Health (1990) 2.03

Salmeterol plus theophylline combination therapy in the treatment of COPD. Chest (2001) 2.01

Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol (1990) 2.00

Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00

Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension (1988) 1.99

Hypothesis: does COPD have an autoimmune component? Thorax (2003) 1.98

Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax (2005) 1.92

Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components. Occup Environ Med (2000) 1.88

Familial dementia caused by polymerization of mutant neuroserpin. Nature (1999) 1.88

Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol (1999) 1.87

Localization of serum-derived alpha 2 macroglobulin in cultured cells and decrease after Moloney sarcoma virus transformation. Cell (1977) 1.86

Role of transcription factors in inflammatory lung diseases. Thorax (1998) 1.85

Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radic Biol Med (1996) 1.83

Diagnosis of pulmonary emphysema by computerised tomography. Lancet (1984) 1.80

Estimation of lung growth using computed tomography. Eur Respir J (2003) 1.78

The SF36 as an outcome measure of services for end stage renal failure. Qual Health Care (1998) 1.76

Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats. Inhal Toxicol (1999) 1.76

Measurement of CT lung density in patients with chronic asthma. Eur Respir J (1997) 1.71

The role of digital imaging and communications in medicine in an evolving healthcare computing environment: the model is the message. J Digit Imaging (1998) 1.70

A kinetic mechanism for the polymerization of alpha1-antitrypsin. J Biol Chem (1999) 1.70

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.70

Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J Immunol (1989) 1.67

Pulmonary hypertension and right ventricular function in patients with COPD. Chest (1988) 1.67

Orchiectomy versus long-acting D-Trp-6-LHRH in advanced prostatic cancer. Br J Urol (1987) 1.66

Inhibitory conformation of the reactive loop of alpha 1-antitrypsin. Nat Struct Biol (1996) 1.66

Evaluation of the humoral immune response in adult dairy cattle three years after vaccination with a bluetongue serotype 8 inactivated vaccine. Vaccine (2011) 1.65

Comparison of neutrophil and capillary diameters and their relation to neutrophil sequestration in the lung. J Appl Physiol (1985) (1993) 1.65

Preoperative severity of emphysema predictive of improvement after lung volume reduction surgery: use of CT morphometry. Chest (2000) 1.63

Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med (1999) 1.63

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest (1997) 1.63

Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep. Vaccine (2009) 1.63

CTLA4 gene polymorphisms are associated with chronic bronchitis. Eur Respir J (2009) 1.62

Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. Eur Respir J (2009) 1.61

Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med (2000) 1.61

Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD. COPD (2010) 1.60

Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest (1999) 1.60

Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J (2008) 1.59

Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci (2000) 1.58

Core to rind distribution of severe emphysema predicts outcome of lung volume reduction surgery. Am J Respir Crit Care Med (2001) 1.57

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J (2009) 1.56

Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax (2004) 1.55

Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc Natl Acad Sci U S A (2000) 1.54

Free radical activity of PM10: iron-mediated generation of hydroxyl radicals. Environ Health Perspect (1997) 1.53

Acute hemodilution: its effect of hemodynamics and oxygen transport in anesthetized man. Ann Surg (1974) 1.52

Increased calcium influx in a monocytic cell line on exposure to ultrafine carbon black. Eur Respir J (2000) 1.51

Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax (2004) 1.48

Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene (2009) 1.48

Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema. Am J Respir Cell Mol Biol (1998) 1.47

Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. Thorax (2008) 1.47

Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax (1996) 1.47

Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax (2010) 1.46

Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program. Genet Epidemiol (2002) 1.46

Diabetes services in the UK: fourth national survey; are we meeting NSF standards and NICE guidelines? Arch Dis Child (2005) 1.45

Alcohol and cor pulmonale in chronic bronchitis and emphysema. BMJ (1993) 1.44

Pathogenic alpha 1-antitrypsin polymers are formed by reactive loop-beta-sheet A linkage. J Biol Chem (2000) 1.43

Urate crystal induced inflammation in the rat: evidence for the combined actions of kinins, histamine and components of complement. Immunol Commun (1972) 1.42